SCHEMBL22149192

SCHEMBL22149192

Cc1ccc(-c2cccc(F)c2C)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
AKR1C3 P42330 2/20 0.42
AKR1C2 P52895 2/20 0.42
ACHE P22303 1/20 0.41
CD274 Q9NZQ7 2/20 0.41
NISCH Q9Y2I1 1/20 0.40
AKR1B10 O60218 1/20 0.40
AKR1C4 P17516 1/20 0.40
AKR1C1 Q04828 1/20 0.40
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
PTPRC P08575 1/20 0.37
PTPN1 P18031 1/20 0.37
KMO O15229 2/20 0.36
GPR3 P46089 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304805 0.89 PTGS2 (0.46) BRD4CREBBPTNKSTNKS2ACHE
SCHEMBL10091244 0.85 PGR (0.44) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL12330295 0.84 TNKS (0.57) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL19935596 0.81 TNKS (0.54) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL10091308 0.80 AKR1C3 (0.42) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL16852356 0.80 AKR1C3 (0.47) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL17840301 0.79 BRD4 (0.40) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL10091242 0.78 WDR5 (0.40) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL27363344 0.77 TNKS (0.43) BRD4CREBBPTNKSTNKS2AKR1C3
SCHEMBL257771 0.77 MEN1 (0.46) BRD4CREBBPTNKSTNKS2AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200199141-A1 PSEUDO TRÖGER'S BASE-DERIVED DIANHYDRIDES AND POLYIMIDES DERIVED FROM PSEUDO TRÖGER'S BASE-DERIVED DIANHYDRIDES UNIV KING ABDULLAH SCI & TECH (SA) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200199141-A1 PSEUDO TRÖGER'S BASE-DERIVED DIANHYDRIDES AND POLYIMIDES DERIVED FROM PSEUDO TRÖGER'S BASE-DERIVED DIANHYDRIDES PARG, PLEC, TARBP1 BRD4 614/4885CREBBP 3536/4885TNKS 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.